Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thomas Lodi"'
Autor:
Chitchamai Siangproh, Sawang Saenghirunvattana, Cecille Lorraine Castillon, Kritsana Sutthisri, Cheewantorn Boonpeng, Thomas Lodi, Supada Chusaktrakul, Maria Christina Gonzales, Chittisak Napairee
Publikováno v:
The Bangkok Medical Journal. :39-42
While previous studies did indeed advance novel treatment methods for NSCLC, the team in Bangkok Hospital found it curious that even in a recent study published in April 2012, the most advanced staging evaluation methods used were mediastinoscopy or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::823b66485c96278100cb3bf2f81a0f93
https://doi.org/10.31524/bkkmedj.2014.02.008
https://doi.org/10.31524/bkkmedj.2014.02.008
Autor:
Nicholas A. Turner, Smitha Zaharoff, Heather King, Scott Evans, Toshimitsu Hamasaki, Thomas Lodise, Varduhi Ghazaryan, Tatiana Beresnev, Todd Riccobene, Rinal Patel, Sarah B. Doernberg, Urania Rappo, Vance G. Fowler, Thomas L. Holland, on behalf of the Antibacterial Resistance Leadership Group (ARLG)
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Staphylococcus aureus bacteremia is a life-threatening infection and leading cause of infective endocarditis, with mortality rates of 15–50%. Treatment typically requires prolonged administration of parenteral therapy, itself as
Externí odkaz:
https://doaj.org/article/a09ef7c8d4244ac5b80e26defc820dae
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279844 (2023)
We aimed to determine if available evidence from a previously conducted systematic literature review was sufficient to conduct a robust network meta-analysis (NMA) using the International Society for Pharmacoeconomics and Outcomes Research Good Pract
Externí odkaz:
https://doaj.org/article/96a142f2528d4c8c9e208516f02151b6
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 953-966 (2020)
Abstract Introduction Hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) are associated with significant healthcare resource utilization (HCRU). This a priori, exploratory, secondary analysis from the ASPECT-NP clinical t
Externí odkaz:
https://doaj.org/article/b0c09aabe77e4ce19a08c673281d0f12
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 1, Pp 107-117 (2020)
Abstract Introduction Outcomes data for patients who received tedizolid for acute bacterial skin and skin-structure infections (ABSSSIs) are scant. We provide a real-world analysis of economic and clinical outcomes following tedizolid use in the outp
Externí odkaz:
https://doaj.org/article/b1797d3a47fe4a12aa431b6eee1a769e
Publikováno v:
Antibiotics, Vol 10, Iss 10, p 1195 (2021)
Introduction: Approximately 3% of hospitalized patients with community-acquired bacterial pneumonia (CABP) develop healthcare-associated Clostridioides difficile infection (HCA-CDI). The validated Davis risk score (DRS) indicates that patients with a
Externí odkaz:
https://doaj.org/article/895a3b1eab52417b9b385054e45f9944